Related Experiment Video
Updated: Apr 5, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
Published on: August 24, 2017
[Discovery and clinical application of mutations in the cancer genome]
Abstract:
Cancer genome/epigenome analyses have identified a wide array of somatic mutations that can confer cancer cell characteristics. These genomic/epigenomic alterations can be targeted for cancer treatment, and, indeed, inhibitors against oncogenic protein-tyrosine kinases have been proved clinically effective. Other types of molecularly targeted therapies, such as epigenetic modifiers, are currently under clinical testing. In addition to the discovery of such driver mutations, profiling of genome/epigenome in cancer becomes especially important in the selection of most appropriate drug in for given cancer patient.
Insights
Cancer genome and epigenome analyses reveal mutations driving cancer. Targeting these alterations, like with protein-tyrosine kinase inhibitors, offers effective cancer treatment strategies and personalized medicine approaches.
Area of Science:
- Oncology
- Genomics
- Epigenetics
Background:
- Cancer development is driven by somatic mutations and epigenetic alterations.
- Genomic and epigenomic profiling is crucial for understanding cancer heterogeneity.
- Targeted therapies based on molecular alterations have shown clinical efficacy.
Purpose of the Study:
- To highlight the importance of cancer genome and epigenome analyses.
- To emphasize the role of molecularly targeted therapies in cancer treatment.
- To underscore the significance of profiling for personalized cancer drug selection.
Main Methods:
- Comprehensive analysis of cancer genomes and epigenomes.
- Identification of driver mutations and epigenetic modifications.
- Review of clinical data for targeted therapy efficacy.
Main Results:
- Numerous somatic mutations conferring cancer cell characteristics have been identified.
- Targeted therapies, including protein-tyrosine kinase inhibitors, are clinically effective.
- Epigenetic modifiers are emerging as promising therapeutic agents.
Conclusions:
- Cancer genome/epigenome profiling is essential for identifying actionable targets.
- Personalized medicine strategies rely on understanding individual cancer molecular profiles.
- Targeted therapies offer a pathway to more effective and individualized cancer treatment.
More Related Videos
Related Concept Videos
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

